Company Filing History:
Years Active: 2024-2025
Title: Zonghao Qiu: Innovator in Circular RNA Technology
Introduction
Zonghao Qiu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant nucleic acid molecules. With a total of 2 patents, his work focuses on innovative methods for preparing circular RNA, which has important applications in various medical fields.
Latest Patents
Zonghao Qiu's latest patents include two groundbreaking inventions related to recombinant nucleic acid molecules. The first patent describes a recombinant nucleic acid molecule and its application in the preparation of circular RNA. This invention introduces a Clean PIE system with a novel structure that enhances the accuracy of circular RNA molecules while reducing their immunogenicity. This technology holds promise for applications in nucleic acid vaccines, therapeutic protein expression, and gene therapy.
The second patent focuses on a recombinant nucleic acid molecule based on point mutation of translation initiation elements. Similar to the first, this invention provides a Clean PIE system for in vitro preparation of circular RNA. It aims to improve the sequence accuracy and reduce secondary structure changes, thereby minimizing immunogenicity. This innovation also has significant potential in the fields of nucleic acid vaccines and gene therapy.
Career Highlights
Zonghao Qiu is currently associated with Purecodon (Hong Kong) Biopharma Ltd., where he continues to advance his research in biotechnology. His work is characterized by a commitment to developing cutting-edge solutions that address critical challenges in medicine and therapeutics.
Collaborations
Zonghao collaborates with notable colleagues, including Qiangbo Hou and Yang Zhao. Their combined expertise contributes to the innovative research environment at Purecodon, fostering advancements in biopharmaceuticals.
Conclusion
Zonghao Qiu is a leading inventor in the field of circular RNA technology, with patents that pave the way for future advancements in medical applications. His contributions are poised to make a significant impact on the development of new therapeutic strategies.